189 related articles for article (PubMed ID: 20149868)
21. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
Atuah KN; Walter E; Merkle HP; Alpar HO
J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
[TBL] [Abstract][Full Text] [Related]
22. Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine.
Tannergren C; Petri N; Knutson L; Hedeland M; Bondesson U; Lennernäs H
Clin Pharmacol Ther; 2003 Nov; 74(5):423-36. PubMed ID: 14586383
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
[TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.
Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2010 Aug; 395(1-2):309-16. PubMed ID: 20635476
[TBL] [Abstract][Full Text] [Related]
26. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
27. Formulation and evaluation of nasal mucoadhesive microspheres of sumatriptan succinate.
Jain SA; Chauk DS; Mahajan HS; Tekade AR; Gattani SG
J Microencapsul; 2009 Dec; 26(8):711-21. PubMed ID: 19888880
[TBL] [Abstract][Full Text] [Related]
28. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part II: In vitro/in vivo evaluation.
Monti D; Burgalassi S; Rossato MS; Albertini B; Passerini N; Rodriguez L; Chetoni P
Int J Pharm; 2010 Nov; 400(1-2):32-6. PubMed ID: 20728514
[TBL] [Abstract][Full Text] [Related]
29. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
30. [Studies on melatonin gelatin microspheres for intranasal administration].
Chen JM; Mao SR; Bi DZ
Yao Xue Xue Bao; 2000 Oct; 35(10):786-9. PubMed ID: 11372449
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
32. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.
Hwang SM; Kim DD; Chung SJ; Shim CK
J Control Release; 2008 Jul; 129(2):100-6. PubMed ID: 18538437
[TBL] [Abstract][Full Text] [Related]
33. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
[TBL] [Abstract][Full Text] [Related]
34. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
35. Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers.
Petri N; Borga O; Nyberg L; Hedeland M; Bondesson U; Lennernas H
Int J Clin Pharmacol Ther; 2006 Feb; 44(2):71-9. PubMed ID: 16502766
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Houston B; Oosterhuis B; Bjerrum OJ; Rowland M; Garner C
Eur J Pharm Sci; 2010 May; 40(2):125-31. PubMed ID: 20307657
[TBL] [Abstract][Full Text] [Related]
37. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
38. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
39. Nasal administration of ondansetron using a novel microspheres delivery system Part II: ex vivo and in vivo studies.
Mahajan HS; Gattani SG
Pharm Dev Technol; 2010 Dec; 15(6):653-7. PubMed ID: 20020823
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
Segall N; Grubbe RE; Levy AL; Maloney MJ; Nayak AS; Kittner B; Quesada JT
Allergy Asthma Proc; 2008; 29(4):380-5. PubMed ID: 18702885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
